Giving drug researchers control of their data


Iguess I’ve been digitizing for my entire career, 20 years,” said Michael Montello, senior vice president of R&D technology at GlaxoSmithKline. “I remember the first data warehouse I implemented in discovery . . . And here we are still talking about digital transformation.”

Montello was reminiscing at the Bio-IT World Conference in September, where he discussed the past 3 years of GSK’s digitization initiative. Peers from Pfizer, Roche, and Eli Lilly and Company joined him, describing similar programs at their firms in drug discovery data management.

Their discussion had a familiar ring to it: break down function silos, establish central data management, develop standard terminologies. In fact, a regular conference attendee may well have shared Montello’s observation: “Here we are again.”

But there is no question that equipping labs with information technology is a rapidly changing endeavor given the now-ubiquitous use of cloud computing and the soon-to-be ubiquitous deployment of artificial intelligence and machine learning. And the velocity of change in drug discovery IT is increased by something advancing even more rapidly—science.

World Top Scientists Awards

Visit Our Website 🌐: worldtopscientists.com
Nominate Now📝: https://worldtopscientists.com/award-nomination/?ecategory=Awards&rcategory=Awardee
Contact us ✉️: contact@worldtopscientists.com

#Sciencefather #ResearchAwards #WorldTopScientistsAwards  #professors #doctor #researchers

Here Connected With:
=====================
Facebook:  www.facebook.com/profile.php?id=100094128235109
Twitter:  twitter.com/Topscienti50880
Linked in:  www.linkedin.com/in/lisa-ray-6a0768282/
Pinterest:  in.pinterest.com/topscientists/
Blog:  scientistsawards25.blogspot.com/
Instagram:  www.instagram.com/lisa__ray__shery/

Comments

Popular posts from this blog

Kaveri Engine Ready for Inflight Testing

ISRO to Launch US Communications Satellite Bluebird

Freshwater Species at Risk of Extinction